The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC).
 
Hans J. Hammers
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - ARMO BioSciences; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Corvus Pharmaceuticals; exelixis; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Novartis; Pfizer
 
Dendra Vonmerveldt
Employment - University of Texas Southwestern Medical Center - Simmons Cancer Center
 
Chul Ahn
Honoraria - Celltrion
Consulting or Advisory Role - Macrogen
Travel, Accommodations, Expenses - Macrogen
 
Rosa Maria Nadal
No Relationships to Disclose
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; Harpoon therapeutics; Kleo Pharmaceuticals; Tizona Therapeutics, Inc.
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Compugen; Janssen Oncology; Merck; Pfizer; Pierre Fabre; Potenza Therapeutics; Roche/Genentech; Tizona Therapeutics, Inc.
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Patents licensed to BMS (Inst); Patents licensed to Potenza Therapeutics (Inst)
Travel, Accommodations, Expenses - AACR; ASCO; Merck Sharp & Dohme; Pfizer; Roche/Genentech
 
Michael Ryan Folkert
No Relationships to Disclose
 
Aaron Michael Laine
No Relationships to Disclose
 
Kevin Dale Courtney
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Janssen
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma; Astellas Pharma (Inst); Astellas Pharma (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); Lilly (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Peloton Therapeutics (Inst); Proacta (Inst); PSMA Development Company (Inst); Stemline Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
James Brugarolas
Consulting or Advisory Role - Arrowhead Pharmaceuticals; Exelixis
Research Funding - Arrowhead Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent of HIF-2 biomarker (Inst); Patent pertaining HIF2a resistance mutations (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Daniel Y. Song
No Relationships to Disclose
 
Raquibul Hannan
Research Funding - Dendreon (Inst); Prometheus (Inst)
 
Michael Anthony Carducci
Consulting or Advisory Role - Abbvie; Astellas Pharma; Foundation Medicine; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Gilead Sciences (Inst); pfizer (Inst)